BCL2 and breast cancer: This proapoptotic effect was caused by the activation of the intrinsic signaling pathway, in particular owing to the profound down-regulation of the antiapoptotic molecules Bcl-2 and Bcl-xL, an effect that was previously suggested as a mechanism of action of copanlisib in breast cancer cells21.